US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 2.3600
  • -0.4889-17.16%
Close Sep 27 16:00 ET
  • 2.3700
  • +0.0100+0.42%
Post 19:22 ET
14.51MMarket Cap-825P/E (TTM)

Aytu BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aytu BioPharma Q4 2024 Earnings Date

Currency：USDSep 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
18.30M
17.98M
-325.00K
Miss Est.
-40.45%
-41.51%
-1.78%
EPS
-0.45
-0.82
-0.37
Miss Est.
+23.73%
-38.98%
-82.26%
Analyst Rating
Buy

Jul 31, 2024

Aytu BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 15.554M--
--2025/Q1-- / 13.768M--
Sep 26, 20242024/Q417.976M / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--
Feb 14, 20242024/Q222.934M / 21.745M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 15.554M--
--2025/Q1-- / 13.768M--
Sep 26, 20242024/Q417.976M / 18.301M--
May 15, 20242024/Q317.993M / 17.346M--
Feb 14, 20242024/Q222.934M / 21.745M--

Unlock Free Earnings Estimates

Aytu BioPharma Earnings Reports

  • Aytu BioPharma | 10-K: FY2024 Annual Report

    Sep 26 16:08 ET

  • Aytu BioPharma | 10-Q: Q3 2024 Earnings Report

    May 15 22:28 ET

  • Aytu BioPharma | 10-Q: Q2 2024 Earnings Report

    Feb 14 16:17 ET

  • Aytu BioPharma | 10-Q: Q1 2024 Earnings Report

    Nov 14, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday+0.29%